VTVT
vTv Therapeutics Inc. Class A Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
vTv Therapeutics (VTVT) Stock: Buy, Sell, or Hold?
$20.69
-0.78 (-3.63%)
▼
5d:
-4.83%
30d:
-24.82%
90d:
-31.31%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$22.87 – $29.26
Position: OVERSOLD
Forward P/E & Valuation
-5.3x
Next 12M consensus est.
Wall Street Target
$55.67
+169.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$20.41 / $26.31
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: VTVT shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When VTVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VTVT is currently trading at $20.69, which is considered oversold relative to its 30-day fair value range of $22.87 to $29.26.
Technical Outlook: Technically, VTVT is in a strong downtrend. The price is currently testing key support at $20.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $55.67 (+169.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VTVT is in a strong downtrend. The price is currently testing key support at $20.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $55.67 (+169.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$22.87 -
$29.26
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$22.87 -
$29.26
Current vs Trading Range
OVERSOLD
Support Level
$20.41
Resistance Level
$26.31
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- BULLISH: Trading 169.1% below Wall St target ($55.67)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.34
Wall Street Target
$55.67
(+169.1%)
Profit Margin
-12.9%
Share VTVT Analysis
Share this live VTVT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VTVT)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $VTVT, with a target price of $32 and emphasis on low float volume and a potential V-shaped reversal pattern.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VTVT Research Pages
